This well-known drug may also cure skin cancer: “But don’t experiment yourself”

Door Belgian

When melanoma cells try to survive cancer treatment, they stop multiplying to “hide” from the immune system. “These cells could later form a new tumor mass,” explains cancer researcher Eleonora Leucci (KU Leuven). «But in order to survive the cancer treatment, those inactive cells have to keep their ‘energy factories’ – the mitochondria – running all the time. Since mitochondria are descended from bacteria that have come to live in cells over time, they are very vulnerable to a specific type of antibiotic. That gave us the idea to use these antibiotics as a remedy for melanoma.”

The researchers implanted tumor cells from patients into mice, which were then treated with antibiotics, either as the sole treatment or in combination with existing anti-melanoma therapies. “The antibiotics quickly killed many cancer cells and could therefore be used to save precious time: the time it takes for immunotherapy to take effect,” says Leucci. «In tumors that no longer responded to therapies, the antibiotics extended the lifespan of the mice. In some cases, the mice even healed.”

The researchers worked with antibiotics that are rarely used against bacterial infections due to increasing antibiotic resistance. However, that resistance has no effect on the effectiveness of the treatment in this study, explains Leucci. “The cancer cells appear to be very sensitive to these antibiotics. We can therefore start using the antibiotics as a medicine against cancer instead of against bacterial infections.”

See also  Shower in the morning or in the evening? We explain the differences! - Naturopathy & naturopathic specialist portal

Don’t experiment yourself

However, melanoma patients should not start experimenting themselves, warns Leucci. “Our findings are based on research in mice, so we don’t know how effective this treatment is in humans. Our study reports only one case in humans. A melanoma patient was given antibiotics to treat a bacterial infection, and this caused a resistant melanoma to respond again to standard treatment. This result is encouraging, but more research and more clinical studies are needed to study the use of antibiotics as a cancer treatment. Together with oncologist Oliver Bechter (KU Leuven/UZ Leuven), who is co-author of this study, we are exploring our options.”


Leave a Comment